503 related articles for article (PubMed ID: 17077645)
1. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
2. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
3. Intrarectal administration of milk fat globule epidermal growth factor-8 protein ameliorates murine experimental colitis.
Otani A; Ishihara S; Aziz MM; Oshima N; Mishima Y; Moriyama I; Yuki T; Amano Y; Ansary MM; Kinoshita Y
Int J Mol Med; 2012 Mar; 29(3):349-56. PubMed ID: 22200667
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
[TBL] [Abstract][Full Text] [Related]
5. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
9. Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Engel MA; Kellermann CA; Burnat G; Hahn EG; Rau T; Konturek PC
J Physiol Pharmacol; 2010 Feb; 61(1):89-97. PubMed ID: 20228420
[TBL] [Abstract][Full Text] [Related]
10. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
11. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
Kitamura K; Nakamoto Y; Kaneko S; Mukaida N
J Leukoc Biol; 2004 Dec; 76(6):1111-7. PubMed ID: 15339938
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
Seguí J; Gironella M; Sans M; Granell S; Gil F; Gimeno M; Coronel P; Piqué JM; Panés J
J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
14. IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
Mudter J; Yu J; Amoussina L; Weigmann B; Hoffman A; Rücknagel K; Galle PR; Neurath MF
Arch Immunol Ther Exp (Warsz); 2009; 57(5):369-76. PubMed ID: 19693649
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice.
He J; Liang J; Zhu S; Zhao W; Zhang Y; Sun W
Eur J Pharmacol; 2011 Nov; 670(1):229-35. PubMed ID: 21925164
[TBL] [Abstract][Full Text] [Related]
16. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
17. IL-10 gene therapy prevents TNBS-induced colitis.
Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
[TBL] [Abstract][Full Text] [Related]
19. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q
Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis.
Li XL; Cai YQ; Qin H; Wu YJ
Can J Physiol Pharmacol; 2008 Dec; 86(12):841-9. PubMed ID: 19088805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]